Constantin Tamvakopoulos Selected Research

Constantin Tamvakopoulos Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 02/2007
7	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 08/2008
5	Breast Neoplasms (Breast Cancer) 08/2019 - 03/2016
4	Obesity 11/2010 - 04/2010
2	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2008
2	Inflammation (Inflammations) 01/2018 - 05/2013
2	Hepatocellular Carcinoma (Hepatoma) 02/2014 - 11/2013
2	Body Weight (Weight, Body) 04/2010 - 01/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Retinal Degeneration 01/2022
1	Eye Diseases (Eye Disease) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019
1	Parkinson Disease (Parkinson's Disease) 11/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017
1	Dyskinesias (Dyskinesia) 11/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014
1	Experimental Arthritis 01/2010
1	Hypersensitivity (Allergy) 01/2010
1	Rheumatoid Arthritis 01/2010
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2008
1	Colonic Neoplasms (Colon Cancer) 02/2007
1	Tics (Tic) 07/2005
1	Ganglion Cysts (Ganglion) 08/2002

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 03/2016 - 10/2008
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2021 - 03/2011
5	Peptides (Polypeptides)IBA 02/2021 - 08/2002
4	Gemcitabine FDA Link 01/2022 - 04/2014
4	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2017 - 03/2011
2	ProdrugsIBA 01/2022 - 02/2021
2	Sunitinib (Sutent)FDA Link 06/2017 - 03/2016
2	Testosterone (Sustanon)FDA Link 01/2017 - 10/2008
2	AndrogensIBA 04/2014 - 03/2011
2	Leuprolide (Lupron)FDA LinkGeneric 03/2011 - 10/2008
2	Bombesin Receptors (Bombesin Receptor)IBA 05/2010 - 04/2010
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Thioctic Acid (Lipoic Acid)IBA 01/2022
1	CarbamatesIBA 01/2022
1	CarbonatesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 04/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	OximesIBA 02/2021
1	AldehydesIBA 02/2021
1	Lapatinib (GW572016)FDA Link 08/2019
1	Phosphotransferases (Kinase)IBA 08/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 11/2017
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2017
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 11/2017
1	Dopamine (Intropin)FDA LinkGeneric 11/2017
1	2-oxindole (oxindole)IBA 06/2017
1	Protein Kinase InhibitorsIBA 01/2017
1	PyrazinesIBA 01/2017
1	EnzymesIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	LigandsIBA 01/2017
1	Angiogenesis InhibitorsIBA 03/2016
1	Therapeutic UsesIBA 12/2014
1	PolymersIBA 02/2014
1	Sorafenib (BAY 43-9006)FDA Link 11/2013
1	Ethiodized Oil (Ethiodol)FDA Link 11/2013
1	Toll-Like Receptor 7IBA 05/2013
1	LipidsIBA 05/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2013
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 11/2010
1	AmidesIBA 08/2010
1	Carboxylic AcidsIBA 05/2010
1	bombesin receptor subtype 3IBA 04/2010
1	Liposomes (Liposome)IBA 01/2010
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	dexamethasone 21-phosphate FDA LinkGeneric 01/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2010
1	Biomarkers (Surrogate Marker)IBA 10/2008
1	IsotopesIBA 08/2008
1	AminesIBA 08/2008
1	dimethoxycurcuminIBA 02/2007
1	CurcuminIBA 02/2007
1	PhytochemicalsIBA 02/2007
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 07/2005
1	AcidsIBA 07/2005

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2010
2	Drug Therapy (Chemotherapy) 04/2021 - 02/2007
2	Castration 01/2017 - 03/2016
1	Precision Medicine 02/2021
1	Lasers (Laser) 02/2021
1	Ligation 02/2021
1	Oral Administration 04/2010
1	Chemoprevention 02/2007